1. Home
  2. ARTL vs PAPL Comparison

ARTL vs PAPL Comparison

Compare ARTL & PAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • PAPL
  • Stock Information
  • Founded
  • ARTL 2011
  • PAPL 2015
  • Country
  • ARTL United States
  • PAPL Canada
  • Employees
  • ARTL N/A
  • PAPL N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • PAPL Finance: Consumer Services
  • Sector
  • ARTL Health Care
  • PAPL Finance
  • Exchange
  • ARTL Nasdaq
  • PAPL Nasdaq
  • Market Cap
  • ARTL 3.3M
  • PAPL 2.8M
  • IPO Year
  • ARTL N/A
  • PAPL 2023
  • Fundamental
  • Price
  • ARTL $1.02
  • PAPL $0.11
  • Analyst Decision
  • ARTL
  • PAPL Strong Buy
  • Analyst Count
  • ARTL 0
  • PAPL 2
  • Target Price
  • ARTL N/A
  • PAPL $5.25
  • AVG Volume (30 Days)
  • ARTL 1.2M
  • PAPL 2.8M
  • Earning Date
  • ARTL 05-16-2025
  • PAPL 04-14-2025
  • Dividend Yield
  • ARTL N/A
  • PAPL N/A
  • EPS Growth
  • ARTL N/A
  • PAPL N/A
  • EPS
  • ARTL N/A
  • PAPL N/A
  • Revenue
  • ARTL N/A
  • PAPL $2,848,365.00
  • Revenue This Year
  • ARTL N/A
  • PAPL $7.18
  • Revenue Next Year
  • ARTL N/A
  • PAPL $25.02
  • P/E Ratio
  • ARTL N/A
  • PAPL N/A
  • Revenue Growth
  • ARTL N/A
  • PAPL 13.01
  • 52 Week Low
  • ARTL $0.82
  • PAPL $0.11
  • 52 Week High
  • ARTL $1.59
  • PAPL $2.10
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 52.13
  • PAPL 18.91
  • Support Level
  • ARTL $0.99
  • PAPL $0.11
  • Resistance Level
  • ARTL $1.05
  • PAPL $0.12
  • Average True Range (ATR)
  • ARTL 0.07
  • PAPL 0.03
  • MACD
  • ARTL 0.00
  • PAPL -0.01
  • Stochastic Oscillator
  • ARTL 30.00
  • PAPL 5.74

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About PAPL Pineapple Financial Inc.

Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.

Share on Social Networks: